However, the Kaplan–Meier test and the subsequent log-rank comparison test establish that there was no correlation between the grade of UBE2O immunohistochemical staining and prostate cancers’ biochemical recurrence, clinical recurrence, or OS. This evidence concerns the gene UBE2O and prostate carcinoma.